Choi, YoonJung <br/><br/>
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVOŽ (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.  [electronic resource] 

 -  Drug design, development and therapy  2015 
 - 4127-35 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1177-8881 
<br/><br/><label>Standard No.: </label>10.2147/DDDT.S86725  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Area Under Curve<br/>Chemistry, Pharmaceutical<br/>Cross-Over Studies<br/>Drug Combinations<br/>Esomeprazole--administration & dosage<br/>Half-Life<br/>Healthy Volunteers<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Models, Biological<br/>Naproxen--administration & dosage<br/>Proton Pump Inhibitors--administration & dosage<br/>Republic of Korea<br/>Young Adult